ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1556

Assessing Calcinosis in Dermatomyositis with Computed Tomography and Calcium Scoring

Prateek Gowda1, Briana Cervantes2, Lisa G. Rider3, Frederick W. Miller4, Marcus Chen4 and Adam Schiffenbauer4, 1NIBIB, Baltimore, MD, 2NIEHS, Silver Spring, MD, 3Environmental Autoimmunity Group, Clinical Research Branch, NIEHS, NIH, Garrett Park, MD, 4National Institutes of Health, Bethesda, MD

Meeting: ACR Convergence 2020

Keywords: Computed tomography (CT), dermatomyositis, Imaging, Measurement, Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Imaging of Rheumatic Diseases Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Calcinosis is a condition in which calcium salts are deposited in and around soft tissue and is observed in up to 30% of adult dermatomyositis (DM) patients and up to 70% of juvenile dermatomyositis (JDM) patients. Clinical assessment of calcinosis is usually conducted with a physical assessment or through radiographic imaging consisting of plain X-rays. However, due to the two-dimensional nature of these X-ray images, much is still not known about the spatial properties of calcification and the relative densities of the lesions. The objective of the study was to utilize whole-body computed tomography (CT) imaging and calcium scoring techniques as tools for calcinosis assessment in a prospective cohort of patients with DM and JDM.

Methods: Thirty-one patients (14 DM and 17 JDM) who fulfilled Bohan and Peter Classification criteria as probable or definite DM, the EULAR-ACR for definite DM, and with calcinosis identified by physical examination or prior imaging studies were included. Non-contrast whole-body CT scans were obtained using generic and ultra-low dose radiation procedures. Scans were read qualitatively and quantitated using imaging software. We calculated the sensitivity and specificity of calcinosis detection against a physician physical exam. We quantified calcinosis burden using the Agatston scoring technique.

Results: We identified five distinct calcinosis patterns: Clustered, Disjoint, Interfascial, Confluent, and Fluid-filled. Patients often exhibited multiple types of calcification. The most common patterns were the Clustered and Interfascial type seen in 19 and 7 patients, respectively. Novel locations of calcinosis were observed, including the cardiac tissue, pelvic and shoulder bursa, and the spermatic cord. The regions of highest and lowest calcinosis occurrence were the proximal legs (86.7%) and head & neck (40%), respectively. There was moderate agreement for calcinosis detection between the physical exam and CT (κ = 0.45, 95% confidence interval [95% CI] 0.38, 0.52). Physician physical exams had a sensitivity of 59% and a specificity of 90% compared to CT detection. Quantitative measures using Agatston scoring for calcinosis were used in regional distributions across the body. Total average Agatston score, normalized by patient height, was 3128.52 ± 5868.52 (adult DM: 1741.93 ± 2347.21, JDM: 4630.67 ± 8024.76), with no difference by clinical subgroup. A higher calcium score correlated with higher Physician Global Damage, Calcinosis Severity scores, and disease duration.

Conclusion: Whole-body CT scans and the Agatston scoring metric define distinct calcinosis patterns and provide novel insights relating to calcinosis in DM and JDM patients. Physician physical examinations underrepresented the presence of calcium. Calcium scoring of CT scans correlated with clinical measures, which suggests that this method may be used to assess calcinosis and follow its progression.


Disclosure: P. Gowda, None; B. Cervantes, None; L. Rider, NIEHS, NIH, 2, Cure JM Foundation, 2, Bristol Myers Squibb, 2, Hope Pharmaceuticals, 2, Eli Lilly and Company, 9, MedImmune/AstraZeneca, 9; F. Miller, None; M. Chen, None; A. Schiffenbauer, None.

To cite this abstract in AMA style:

Gowda P, Cervantes B, Rider L, Miller F, Chen M, Schiffenbauer A. Assessing Calcinosis in Dermatomyositis with Computed Tomography and Calcium Scoring [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/assessing-calcinosis-in-dermatomyositis-with-computed-tomography-and-calcium-scoring/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-calcinosis-in-dermatomyositis-with-computed-tomography-and-calcium-scoring/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology